tradingkey.logo
tradingkey.logo
Search

Advanced Biomed Inc

ADVB
Add to Watchlist
6.500USD
+0.120+1.88%
Market hours 09/23, 10:35ET
10.72MMarket Cap
0.12P/E TTM

About Advanced Biomed Inc Company

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Inc Profile

Ticker SymbolADVB
Company nameAdvanced Biomed Inc
IPO dateMar 06, 2025
CEO- -
Number of employees31
Security typeOrdinary Share
Fiscal year-endMar 06
Address401 Ryland St
CityRENO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code89502
Phone1862120510823
Websitehttp://www.advanbiomed.com/
Ticker SymbolADVB
IPO dateMar 06, 2025
CEO- -

Company Executives of Advanced Biomed Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Xiaomin Chen
Mr. Xiaomin Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
270.00K
--
Mr. Xiaomin Chen
Mr. Xiaomin Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
270.00K
--
Mr. Mingze Yin
Mr. Mingze Yin
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Ms. Jing Zhang
Ms. Jing Zhang
Independent Director
Independent Director
--
--
Ms. I Kei Cheang
Ms. I Kei Cheang
Independent Director
Independent Director
--
--
Mr. Mingyue Cai
Mr. Mingyue Cai
Independent Director
Independent Director
--
--
Mr. Mingze Yin
Mr. Mingze Yin
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
Ms. Jing Zhang
Ms. Jing Zhang
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Xiaomin Chen
Mr. Xiaomin Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
270.00K
--
Mr. Xiaomin Chen
Mr. Xiaomin Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
270.00K
--
Mr. Mingze Yin
Mr. Mingze Yin
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Ms. Jing Zhang
Ms. Jing Zhang
Independent Director
Independent Director
--
--
Ms. I Kei Cheang
Ms. I Kei Cheang
Independent Director
Independent Director
--
--
Mr. Mingyue Cai
Mr. Mingyue Cai
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Advanced Biomed Inc?

The top five shareholders of Advanced Biomed Inc are: Mr. Xiaomin Chen

How many institutions hold shares of Advanced Biomed Inc (ADVB)?

As of 2026Q1, 6 institutions hold shares of Advanced Biomed Inc, with a combined market value of approximately 1.99K, accounting for 0.12% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -12429.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.